Natera

YTD

ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).

CEO

Stephen Leonard Chapman

CEOStephen Leonard Chapman

Employees

6,140

Employees6,140

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2003

Founded2003

Employees

6,140

Employees6,140

NTRA Key Statistics

Market cap

47.62B

Market cap47.62B

Price-Earnings ratio

-241.35

Price-Earnings ratio-241.35

Dividend yield

—

Dividend yield—

Average volume

964.59K

Average volume964.59K

High today

$331.88

High today$331.88

Low today

$321.19

Low today$321.19

Open price

$324.14

Open price$324.14

Volume

692.84K

Volume692.84K

52 Week high

$343.18

52 Week high$343.18

52 Week low

$157.43

52 Week low$157.43

Stock Snapshot

With a market cap of 47.62B, Natera(NTRA) trades at $330.31. The stock has a price-to-earnings ratio of -241.35.

On 2026-09-09, Natera(NTRA) stock moved within a range of $321.19 to $331.88. With shares now at $330.31, the stock is trading +2.8% above its intraday low and -0.5% below the session's peak.

Trading volume for Natera(NTRA) stock has reached 692.84K, versus its average volume of 964.59K.

Over the past 52 weeks, Natera(NTRA) stock has traded between a high of $343.18 and a low of $157.43.

NTRA News

TipRanks 15h

Natera assumed with a Buy at UBS

UBS assumed coverage of Natera (NTRA) with a Buy rating and $435 price target Nateria is the leader in the large and growing MRD market, with additional support...

Nasdaq 1d

Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia)

Key Points Stanley Druckemiller holds some smaller positions in Amazon and Alphabet. His largest stockholding is a company called Natera, which does DNA diagn...

Simply Wall St 2d

Can Natera Justify Its Valuation As Signatera Lymphoma Data Lifts Sentiment? - simplywall.st

...

Analyst ratings

85%

of 26 ratings

Buy

84.6%

Hold

15.4%

Sell

More NTRA News

TipRanks 2d

Natera initiated with a Buy at Rothschild & Co Redburn

Rothschild & Co Redburn initiated coverage of Natera (NTRA) with a Buy rating and $385 price target Natera is the market leader in molecular residual disease te...

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Flowserve

EOG Resources

iShares MSCI Emerging Mar…

CSX

Alcoa

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.